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Abstract
Nephrometry scores are designed to characterize tumors and stratify the surgical complexity. It remains unclear as to which nephrometry score 
can accurately predict the surgical outcomes. We aimed to assess the utility of radius, exophytic/endophytic, nearness, anterior/posterior, location 
(RENAL), preoperative aspects and dimensions used for anatomic classifications (PADUA), and centrality index (C-index) nephrometry scores 
for predicting the strict Trifecta achievement from a single institution series robotic-assisted partial nephrectomy (RAPN). We retrospectively 
identified the prospectively maintained robotic surgery database records of 91 patients who underwent RAPN between June 2015 and  September 
2020 in Antalya Training and Research Hospital. The main outcome of the study was the achievement of strict Trifecta (negative surgical 
margin, no major urologic complications, warm ischemia time ≤25 min, and ≥85% preservation of estimated glomerular filtration rate). A mul-
tivariable analysis was performed to identify the factors of strict Trifecta success. The mean patient age was 55.82 ± 13.37 years with a median 
clinical tumor size of 3.5 cm (IQR 2.5–4.9). The median RENAL, PADUA, and C-index score were 7(IQR 6–8), 8(IQR 7–10), and 2.01(IQR 
1.64–2.72), respectively. A strict Trifecta could be achieved in 54 patients (59.3%). Clinical tumor size (P = 0.011), RENAL risk groups (low:ref-
erence; intermediate; P = 0.040; high; P = 0.009), PADUA risk groups (low:reference; intermediate; P = 0.044; high; P = 0.001) and C-index risk 
groups (low:reference; high; P = 0.015) were the independent predictors of strict Trifecta attainment in the multivariate analysis. None of the 
nephrometry scores were a superior predictor compared to other nephrometry scores in comparative analysis. RENAL, PADUA, and C-index 
scores were all independent predictors of a strict Trifecta achievement. Our comprehensive comparison of the three scores identified that none of 
the nephrometry scores proved to be inferior to others nephrometry scores.
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Introductıon
The incidental detection of small renal masses has increased 
in the present times, and the cases of renal cell carcinoma 
(RCC) are more frequently diagnosed due to the widespread 
use of imaging modalities for unrelated reasons (1). Partial 
nephrectomy (PN) has become the standard surgical treat-
ment for localized RCC, as it offers a better preservation of 
renal function and an equivalent oncological outcome com-
pared to radical nephrectomy (2, 3). Open, laparoscopic, 
and robotic surgical techniques can be implemented for PN. 
It is noted that robotic-assisted PN (RAPN) is increasingly 
becoming the approach of choice among patients undergo-
ing PN. RAPN overcome some of the technical difficulties 
pertaining to the laparoscopic technique, providing easier 
tumor resection, suturing, and repairing of the renal defect, 
and a shorter learning curve. Several studies on the topic 
point out to the fact that the clinical outcomes of RAPN are 
superior compared to the laparoscopic technique (4).
The main aim of PN should be to completely remove the 
tumor with minimal complication and minimal decrease 
in renal function. In order to simplify and standardize the 
reporting and comparison of the outcomes of PN, Hung et 
al. have proposed “Trifecta”, adopted from radical prosta-
tectomy (5). Trifecta is defined as a combination of negative 
surgical margin, minimal renal function decrease, and no uro-
logical complication. Different definitions of the component 
minimal renal function decrease have been reported. Some 
authors have also reported a warm ischemia time, (WIT) 
≤25 min, to be a component of the Trifecta (6, 7). In a study 
conducted by Sharma et al., Trifecta was defined as WIT 
<30 min (8). In several studies, the authors have applied strict 
Trifecta (negative surgical margin, no complications of grade 
3 or higher, renal function loss <15%, and WIT≤25 min) to 
evaluate the renal function preservation more precisely (9, 10).
The nephrometry scores are designed to characterize tumor, 
facilitate cohort comparisons, and stratify surgical complexity. 
The radius, exophytic/endophytic, nearness, anterior/posterior, 
location (RENAL) nephrometry score, preoperative aspects 
and dimensions used for an anatomic classifications (PADUA) 
score, and the centrality index (C-index) remain the most 
known and used systems (11–13). The importance of these 
nephrometry scores in predicting the perioperative and renal 
functional outcomes of PN has been demonstrated (14–16).
In this study, we aimed to comparatively assess which of 
three nephrometry scores corralates best with strict Trifecta 
achievement in RAPN.
Material and Methods
Study design and participants
Following the approval of the Institutional Review Board 
(approval number = 2020-286), we reviewed the charts of the 
patients who underwent RAPN for a suspicious renal mass 
between June 2015 and September 2020 in Antalya Training 
and Research Hospital. The data were retrospectively noted 
from a prospectively maintained database. The patients with 
solitary kidney (n = 2), missing data (n = 4), and a follow-up 
time shorter than 1 year (n = 40) were excluded from the 
study. The first 25 cases on the learning curve of the surgeons 
performing RAPN were also excluded. The final group for 
the study included 91 patients.
Nephrometry scores
Before the surgery, all the patients underwent a contrast-en-
hanced computed tomograph (CT) or magnetic resonance 
imaging (MRI). RENAL, PADUA, and C-index scores 
were calculated by a radiologist (AGE) and an urologist 
(YA) according to the protocols described for these sys-
tems (11–13). Both the physicians were blinded to patient 
characteristics, the clinical outomes, and the results of the 
other observer’s assessments while they were calculating the 
nephrometry scores. RENAL scores were categorized into 
low-complexity (score 4–6), intermediate-complexity (score 
7–9), and high complexity (score 10–12). The tumor com-
plexity was stratified as low, intermediate, and high if  the cal-
culated PADUA score was 6–7, 8–9, and 10–14, respectively. 
For the C-index score, tumors seperated into two categories 
of >2.5 (low complexity) and <2.5 (high complexity).
Surgical technique
The indication for surgery was elective in all the cases. All 91 
RAPN operations were carried out by two surgeons (MS and 
MA) using the da Vinci XI robotic surgical system (Intuitive 
Surgical Inc, Sunnyvale, CA, USA). Both transperitoneal 
and retroperitoneal accesses were utilized. The decision for 
the surgical approach was taken after assessing the location 
of the tumor and the surgeons’s preference. The vascular 
pedicle was dissected and isolated with the help of vascular 
silicon tapes. The decision to clamp renal hilum was taken 
during the surgery, based on the tumor characteristics and 
intraoperative findings. The tumor was identified visually and 
cut out by a cold scissors with 2–5 mm of the parenchymal 
margin. The tumor bed was oversewn with 3-0 V-lock, paren-
chymal sutures were made using the sliding clip technique.
Clinical assessment
Preoperative demographic data (gender, age, body mass 
index [BMI], and comorbidities), tumor characteristics 
(tumor side, clinical tumor size, RENAL, PADUA, and 
C-index scores), perioperative outcomes (surgical approach, 
WIT, estimated blood loss [EBL], operation time [OT], 
and hospitalization), and pathology features (tumor size, 
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95% confidence intervals (95% CIs) was reported. A P-value 
of less than 0.05 was considered statistically significant.
Results
The descriptive statistics of the study group are shown in 
Table 1. The mean patient age was 55.82 ± 13.37 years, with 
a median clinical tumor size of 3.5 cm ( IQR 2.5–4.9). Most 
patients in the study were male (70.3%), and operated on in 
the transperitoneal approach (81.3%). The mean BMI was 
also noted as 27.13 ± 3.7 kg/m2.
The operative findings and pathological outcomes are 
summarized in Table 2. Median WIT, OT, and EBL were 
24 min (IQR 16–29), 140 min (IQR 120–170), and 100 mL 
(IQR 60–200), respectively. The median pathological tumor 
size was 3.5 cm (IQR 2.5–5), and 74.7% (n = 68) of the 
tumors were RCC, while 25.3% (n = 23) of the tumors were 
benign. A majority of the tumors were stage T1 (94.1%). 
Four (5.9%) patients had a positive surgical margin. At a 
median follow-up of 34 months, no tumor recurrence was 
reported, and no conversion to open surgery was observed. 
The overall complication rate was 11% (n = 10) of which 
only 1.1% (n =  1) was Clavien III. The complications 
included hemorrhage necessitating blood tranfusion (n = 8), 
urine leak necessitating JJ ureteral stent placement, and ileus 
resolved with medical therapy (n = 1).
The association of nephrometry scores and risk groups 
with strict Trifecta achievement is given in Table 3. The 
median RENAL, PADUA, and C-index score were 7 (IQR 
6–8), 8 (IQR 7–10), and 2.01 (IQR 1.64–2.72), respectively. 
Strict Trifecta was achieved in patients with a lower RENAL 
and PADUA score, and a higher C-index score, representing 
a significant difference (all, P < 0.001).
The renal functional change is demonstrated in Table 4. 
Median creatinine was 0.95 mg/dL (IQR 0.82–1.08) before 
the surgery, and it increased to 1.1 mg/dL (IQR 0.92–1.31) 
on the first postoperative day, and 1.01 mg/dL (IQR 0.84–
1.2) 12 months after the surgery. The mean preoperative and 
postoperative eGFR were 82.68 ± 18.79 mL/min/1.73 m2 and 
78.25 ± 19.31 mL/min/1.73 m2, respectively. The reduction in 
eGFR in the first year was statistically significant (P < 0.001).
Table 5 demonsrates the relationship between nephrom-
etry score risk groups and strict Trifecta components. Each 
scoring system was found to have a statistically significant 
association with WIT (P = 0.001 for RENAL, P < 0.001 for 
PADUA and C-index). Additionally, PADUA correlated 
with renal function reduction (P = 0.001).
Strict Trifecta could be achieved in 54 patients (59.3%). 
The most common reason for the failure of strict Trifecta 
was prolonged WIT. Univariate and multivariate analy-
ses were performed to evaluate the preoperative variables 
predicting strict Trifecta achievement (Table 6). The result 
of the multivariate analysis showed that the clinical tumor 
histological sub-types, tumor grade, pathological stage, and 
surgical  margin status) were recorded. There were complica-
tions in the first 30 days after surgery, which were classified 
according to Clavien-Dindo system. OT was defined as the 
time from the placement of trocars to the removal of trocars.
The renal function of the group was evaluated preopera-
tively and 1 year after operation by serum creatinine levels 
and estimated glomerular filtration rate (eGFR), calculated 
by the modification of diet in renal disease (MDRD) for-
mula. Preoperative creatinine levels were measured routinely 
for 3–7 days before the surgery. Absolute and percent change 
in eGFR was calculated based on the difference between the 
preoperative and postoperative up to 12 months.
Strict Trifecta was used for investigating the accomplish-
ment of optimal outcomes of RAPN. The achievement of 
strict Trifecta was defined as the simultaneous fulfillment of 
the following factors: negative surgical margin, WIT≤25 min, 
renal function loss <15%, and no significant perioperative 
complications (Clavien-Dindo grade ≥3).
Statistical analysis
The statistical analysis was done using IBM SPSS Statis-
tics for Windows, Version 23.0 (IBM Corp., Armonk, NY). 
The normality assumptions were controlled by the Shapiro– 
Wilk test. The descriptive analyses were presented using 
mean ± SD, median (IQR), or n (%), where appropriate. The 
categorical data were analyzed by Pearson chi-square and 
Fisher’s Exact test. Mann–Whitney U test and Student’s t 
test were used for the analysis of non-normally and normally 
distributed numerical data, respectively. The paired samples 
t-test was used for parametric comparison of repeated mea-
surements. Friedman test with Bonferroni correction was 
used for the non-parametric comparison of parameters mea-
sured at different times. The receiver operating characteristic 
(ROC) curve analysis was applied to determine the optimal 
cut-off  point of RENAL, PADUA, and C-index scores for 
predicting the achievement of strict Trifecta and area under 
the curve (AUC); sensitivity and specificity were calculated 
and reported with 95% confidence intervals. The optimal 
cut-off  point of measurements was determined as the value 
of the maximum Youden index. Delong’s test was used for 
comparison of AUC values of nephrometry scores. Univar-
iate and multivariate logistic regression analysis was used to 
determine the independent risk factors associated with the 
achievement of strict Trifecta. The variables with P < 0.1 in 
the univariate analyses were further tested in the multivari-
ate model. Since RENAL, PADUA, and C-index score are 
highly correlated, a separate regression model was created 
for each variables. To determine the interobserver reliability 
between the urologist and radiologist for RENAL, PADUA, 
and C-index scores, the intraclass correlation coefficient 
(ICC) was calculated. Odds ratio (OR) with corresponding 
Karamık K et al.
 Journal of Kidney Cancer and VHL 2021; 8(4): 1–12  4
Table 1: Clinical characteristics of patients.
Variables Overall Achieving strict  
Trifecta
Not achieving strict 
Trifecta
P-Value
Number of patients 91 54 37 –
Mean age, (years) 55.82 ± 13.37 56.28 ± 12.83 55.16 ± 14.28 0.698
Gender, n (%)
Male 64(70.3) 38(70.4) 26(70.3) 0.992
Female 27(29.7) 16(29.6) 11(29.7)
Mean BMI, (kg/m2) 27.13 ± 3.7 26.43 ± 3.51 28.16 ± 3.79 0.027
Diabetes, n (%) 11(12.1) 7(13) 4(10.8) 0.999
Hypertension, n (%) 27(29.7) 14(25.9) 13(35.1) 0.345
Atherosclerosis, n (%) 15(16.5) 8(14.8) 7(18.9) 0.604
Surgical approach, n (%)
Transperitoneal 74(81.3) 41(75.9) 33(89.2) 0.111
Retroperitoneal 17(18.7) 13(24.1) 4(10.8)
Tumor side, n (%)
Left 52(57.1) 32(59.3) 20(54.1) 0.622
Right 39(42.9) 22(40.7) 17(45.9)
Median clinical tumor size, (IQR) (cm) 3.5(2.5–4.9) 3(2.3–4.2) 4.6(3.5–5.4) <0.001
Hilar clamping, n (%)
Total clamp 74(81.3) 38(70.4) 36(97.3) 0.001
Off clamp 17(18.7) 16(29.6) 1(2.7)
BMI, body mass index.
size (OR = 0.596 95% CI = 0.4–0.887; P = 0.011), RENAL 
risk groups (low:reference; intermediate; OR = 0.278 95% 
CI = 0.082–0.941; P = 0.040; high; OR = 0.074 95% CI = 
0.011–0.521; P = 0.009), PADUA risk groups (low:reference; 
intermediate; OR = 0.181 95% CI = 0.034–0.958; P = 0.044; 
high; OR = 0.058 95% CI = 0.01–0.333; P = 0.001), and 
C-index risk groups (low:reference; high; OR = 0.163 95% 
CI = 0.038–0.699; P = 0.015) were independent predictors of 
strict Trifecta success.
The ability of the nephrometry scores to predict strict 
Trifecta outcomes was evaluated by ROC curve analy-
sis  (Figure 1). All the scores were good predictors of strict 
Trifecta (AUCs of RENAL, PADUA, and C-index were 
0.782, 0.838, and 0.828, respectively). None of the nephrom-
etry scores were a superior predictor compared to other 
nephrometry scores.
All three nephrometry scores demonstrated good concor-
dance between the two observers (Table 7). The ICC values 
between the radiologist and urologist for RENAL, PADUA, 
and C-index were 0.83, 0.88, and 0.89, respectively.
Discussion
In this study, the ability to predict strict Trifecta for RENAL, 
PADUA, and C-index scores were evaluated. We observed a 
good reproducibility of three nephrometry scores among the 
observers. RENAL, PADUA, and C-index scores were all inde-
pendent predictor of a strict Trifecta achievement. Our com-
prehensive comparison of the three scores identified that none 
of the nephrometry scores proved to be inferior to the others.
The objective of PN is to achieve a satisfactory oncolog-
ical outcome and minimize complications while preserving 
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Table 2: Perioperative outcomes and pathological results.
Variables Overall Achieving strict 
Trifecta
Not achieving strict 
Trifecta
P-Value
Median WIT, (IQR) (min) 24(16–29) 19(0–24) 30(28–32) <0.001
Median OT, (IQR) (min) 140(120–170) 127.5(110–150) 155(140–180) <0.001
Median EBL, (IQR) (mL) 100(60–200) 100(50–200) 150(100–200) 0.044
Median pathological tumor size, (IQR) (cm) 3.5(2.5–5) 2.8(2.1–4) 4.5(3.5–5.5) <0.001
Tumor type, n (%)
Benign 23(25.3) 15(27.8) 8(21.6) 0.507
Malign 68(74.7) 39(72.2) 29(78.4)
Benign subtype (n = 23), n (%)
Angiomyolipoma 7(30.4) 4(26.7) 3(37.5) 0.217
Chronic pyelonephritis 2(8.7) 1(6.7) 1(12.5)
Benign cyst 3(13) 2(13.3) 1(12.5)
Oncocytoma 6(26.1) 6(40) 0(0)
Tubulointerstitial nephritis 1(4.3) 0(0) 1(12.5)
Hydatid cyst 2(8.7) 1(6.7) 1(12.5)
Ksantogranulomatosis 1(4.3) 1(6.7) 0(0)
Metanephric adenoma 1(4.3) 0(0) 1(12.5)
Malign subtype (n = 68), n (%)
Clear 46(67.6) 23(59) 23(79.3) 0.191
Papillary 15(22.1) 11(28.2) 4(13.8)
Chromofobe 7(10.3) 5(12.8) 2(6.9)
Positive surgical margin (n = 68), n (%) 4(5.9) 0(0) 4(13.8) 0.029
Pathological stage (n = 68), n (%)
T1a 38(55.9) 30(76.9)a 8(27.6)b <0.001
T1b 26(38.2) 9(23.1)a 17(58.6)b
T2a 2(2.9) 0(0)a 2(6.9)a
T3a 2(2.9) 0(0)a 2(6.9)a
WHO/ISUP grade (n = 68), n (%)
1 14(20.6) 12(30.8) 2(6.9) 0.051
2 42(61.8) 21(53.8) 21(72.4)
3 11(16.2) 6(15.4) 5(17.2)
4 1(1.5) 0(0) 1(3.4)
(continues)
Table 2: Continued
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Variables Overall Achieving strict 
Trifecta
Not achieving strict 
Trifecta
P-Value
Complication, n (%) 10(11) 4(7.4) 6(16.2) 0.306
Complication grade (n = 10), n (%)
1 1(10) 0(0) 1(16.7) 0.999
2 8(80) 4(100) 4(66.7)
3 1(10) 0(0) 1(16.7)
Hospitalization, (IQR) (days) 3(3–3) 3(3–3) 3(3–3) 0.375
WIT, warm ischemia time; OT, operation time; EBL, estimated blood loss; WHO/ISUP, World Health Organization/International Society of 
Urological Pathology.
Table 3: Overall nephrometry scores and distrubitions.
Overall Achieving strict 
Trifecta
Not achieving strict 
Trifecta
P-Value
Median RENAL, (IQR) 7(6–8) 6(5–7) 8(7–9) <0.001
RENAL risk, n (%)
Low 33(36.3) 28(51.9)a 5(13.5)b <0.001
Moderate 48(52.7) 24(44.4)a 24(64.9)a
High 10(11) 2(3.7)a 8(21.6)b
Median PADUA, (IQR) 8(7–10) 8(7–8) 10(9–11) <0.001
PADUA risk, n (%)
Low 26(28.6) 24(44.4)a 2(5.4)b <0.001
Moderate 36(39.6) 22(40.7)a 14(37.8)a
High 29(31.9) 8(14.8)a 21(56.8)b
Median C-index, (IQR) 2.01(1.64–2.72) 2.47(1.96–3.53) 1.66(1.42–1.89) <0.001
C-index risk, n (%)
Low 31(34.1) 28(51.9) 3(8.1) <0.001
High 60(65.9) 26(48.1) 34(91.9)
RENAL, Radius, exophytic/endophytic, nearness, anterior/posterior, location; PADUA, Preoperative aspects and dimensions used for an 
anatomic classifications; C-index, Centrality index.
renal function to the extend possible. Accordingly, Hung 
et al. (5) introduced the Trifecta to jointly evaluate the onco-
logical outcomes, renal function preservation, and complica-
tions. The Trifecta represents a good tool to asses the success 
of PN. Currently, there is no consensus on the definitions 
used for components of the Trifecta. The renal function 
preservation component of the Trifecta has been interpreted 
differently by the authors (6–10). The only use of WIT≤25 
min does not apply properly to demonstrate long term renal 
functional outcomes. Thus, we used both: an intraoperative 
variable that WIT≤25 min and a 85% eGFR preservation at 
1 year to define a minimal renal function decrease. However, 
the main concept of the Trifecta is the same; negative surgi-
cal margin, minimal renal function decrease, and safety pro-
cedure. In the present study, the positive surgical margin rate 
of 5.9% is in line with other studies on RAPN. Furthermore, 
Nephrometry scores and strict Trifecta
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Table 4: Preoperative and postoperative renal functional outcomes.
Variables Overall Achieving strict 
Trifecta
Not achieving strict 
Trifecta
P-Value
Median preoperative creatinine, (IQR) 
(mg/dL)
0.95(0.82–1.08) 0.93(0.82–1.07) 0.96(0.83–1.1) 0.513
Median postoperative creatinine, (IQR) 
(mg/dL)
1.1(0.92–1.31) 1.07(0.92–1.23) 1.12(0.97–1.38) 0.270
Median first year creatinine, (IQR)  
(mg/dL)
1.01(0.84–1.2) 0.96(0.79–1.12) 1.04(0.87–1.24) 0.131
P <0.001 <0.001 <0.001
Mean preoperative eGFR,  
(mL/min/1.73 m2)
82.68 ± 18.79 83.24 ± 18.11 81.86 ± 19.96 0.734
Mean first year eGFR, (mL/min/1.73 m2) 78.25 ± 19.31 80.8 ± 18.4 74.54 ± 20.25 0.130
P <0.001 0.019 <0.001
Mean eGFR difference -4.51 ± 8.42 -2.61 ± 7.36 -7.27 ± 9.17 0.009
Mean eGFR percent change -5.08 ± 10.22 -2.83 ± 9.05 -8.35 ± 11.04 0.011
eGFR, estimated glomerular filtration rate.
the overall complication rate was 11%, which consistent with 
previous results (6, 7).
The Trifecta achievement rate in previous studies has 
ranged between 31.6% and 87.8% (17–19). Several reasons 
such as surgical experience, different definitions of Tri-
fecta, and surgical approach could have been implicated as 
adversely influencing the outcomes of Trifecta. Moreover, 
patient related factors such as age, preoperative eGFR and 
comorbid status could also affect the renal functional out-
comes. The effect of the surgical technique on Trifecta suc-
cess was investigated, and conflicting results were obtained 
(20–22). Acar et al. studied 133 patients who underwent 
open PN or RAPN, and found that the Trifecta rate was 
similar between the open and robotic techniques (20). Sim-
ilarly, Mehra et al. compared Trifecta rates after open, 
laparoscopic, and robotic PN and found no significant dif-
ferences (21). In contrast, Zargar et al. reported that robotic 
PNs were more likely than laparoscopic approach to achieve 
the Trifecta (22). In a study evaluating the surgical experi-
ence found that increased experience leads to higher propor-
tion of Trifecta (19). In our study, the strict Trifecta rate was 
59.3%. All patients underwent RAPN, and the first 25 cases 
of both the surgeons were excluded to avoid the effect of the 
learning curve.
Nephrometry scores have been developed to describe 
tumor complexity and to standardize the reports of  PN. 
An ideal nephrometry score should have some value in esti-
mating surgical outcomes, and result in consistent scores 
between observers. In this study, we evaluated the RENAL, 
PADUA, and C-index scores which are most known and 
used ones. The correlation between urologist and radiologist 
seems to be sufficient to recommend the use of  RENAL, 
PADUA, and C-index scores. Likewise, good concor-
dance amongst readers was found in a study on interob-
server variability of  the RENAL, PADUA, and C-index 
for robotic and laparoscopic PN patients (8). There are 
many studies investigating the nephrometry scores and PN 
outcomes. The external validation studies demonstrated 
that nephrometry scores associated with perioperative and 
renal functional outcomes (14–16, 23). However, there are 
only four studies on comparative analysis of  nephrometry 
scores to predict the Trifecta success (8, 20, 23, 24). In our 
study, RENAL, PADUA, and C-index scores were all help-
ful to independently predict the strict Trifecta outcomes. 
None of the nephrometry scores were superior predictor 
compared to other nephrometry scores. Egen et al., in a 
single center study including 150 patients, also support our 
finding that RENAL, PADUA, and Mayo Adhesive Prob-
ability (MAP) scores were independent predictors of  the 
Trifecta (24). Crockett et al. reported the outcomes of  322 
RAPNs, and evaluated RENAL, PADUA, and Simplified 
PADUA REnal classification (SPARE) scores. PADUA and 
SPARE had superior predictors in terms of Trifecta (23). In 
another study, the Trifecta outcomes of  50 patients using 
RENAL, PADUA, and C-index scores had been evaluated. 
This study revealed that only C-index correlated with the 
Karamık K et al.
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RENAL 0.782(95% CI: 0.686–0.877; p < 0.01) ≤7.5 77.8 67.6 0.092 0.354 0.809
PADUA 0.838(95% CI: 0.753–0.923; p < 0.01) ≤8.5 77.8 83.8
C-index 0.828(95% CI: 0.744–0.913; p < 0.01) ≥1.895 83.8 75.7
Figure 1: Receiver operating characteristic analysis for RENAL, PADUA, and C-index score to predict the achievement of strict 
Trifecta.
Trifecta achievement. However, there was no univariate and 
multivarite analyses in this study  (8). Contradictory to the 
above mentioned studies, Acar et al. noted that none of  the 
RENAL, PADUA, and C-index scores showed significant 
association to predict Trifecta outcomes. On the other hand, 
the surgeon’s clinical judgement which was evaluated by 
visual analogue score was more efficient than nephrometry 
scores to predict Trifecta (25). Although it is subjecitve, this 
study shows that the clinical opinion and experience of  the 
surgeon who will perform the operation are also important 
for the favorable outcome.
The predictors of Trifecta has been evaluated by several 
studies. In a Japanese multicenter study, tumor diameter, 
EBL and hilar location of the tumor were the independent 
predictors of Trifecta (7). RENAL score failed to have such 
a link in the multivariate analysis. Cetindag et al. Published 
a retrospective case series of laparoscopic PN with 128 
patients, and reported that the tumor size was only a predic-
tor of Trifecta (10). In a similar study including 63 patients 
undergoing laparoscopic PN in T1a renal masses, Osaka 
et al. reported that the tumor size and surgeon’s learning 
curve were predictors of Trifecta outcomes (26). Similar to 
this findings, the experience of the surgeon and the size of 
the tumor independently predicted Trifecta outcomes (19). 
Another study reported that the significant predictors of 
Trifecta success were the tumor size, EBL, OT, robotic sur-
gery, and high risk RENAL scores in the multivariate anal-
ysis (22). Harke et al. noted that the PADUA score was only 
a predictor of Trifecta (27). Conversely, the PADUA score 
was not associated with Trifecta outcomes (28). In this study, 
clinical tumor size and nephrometry scores were significant 
predictors of strict Trifecta. There were inconsistencies in 
the predictive factors for Trifecta achievement. This can be 
attributed to the surgical experience, different definitions of 
Trifecta and surgical approach.
The present study has several limitations. Firstly, our data-
base is prospectively recorded, and the analysis is carried 
out is retrospective. Secondly, the study involved a limited 
number of patients within a single center. Finally, RAPNs 
were performed by 2 surgeons. However, both surgeons have 
extensive experience with open, laparoscopic, and robotic 
PNs. Additionally, as we want to minimize the effects of the 
surgeons’ learning curve of RAPN, we excluded the first 25 
patients for both surgeons.
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Table 7: Concordance between urologist’s and radiologist’s 







RENAL score 0.832 0.756–0.886
PADUA
Polar location 0.822 0.742–0.879
Exophytic rate 0.876 0.817–0.916
Renal rim 0.825 0.746–0.881
Renal sinus 0.656 0.521–0.759
UCS 0.772 0.674–0.844
Tumor size 0.911 0.867–0.940
PADUA score 0.888 0.834–0.924
C-index 0.896 0.847–0.930
RENAL, Radius, exophytic/endophytic, nearness, anterior/ 
posterior, location; PADUA, Preoperative aspects and dimensions 
used for an anatomic classifications; C-index; UCS, urinary  
collecting system.
Conclusion
Based on the results of this study, we suggest using RENAL, 
PADUA, and C-index scores to predict strict Trifecta out-
comes preoperatively, with reproducible interobserver agree-
ment. These scoring systems should undergo an external 
validation in prospective study with larger study group to 
predict the Trifecta success.
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